Home » Topics » BioWorld Asia

BioWorld Asia
RSS

XTLs Trimera HBV Mouse Model Demonstrates Antiviral Efficacy

May 26, 1999

Israel Seeks European Partners

May 26, 1999

Oxford Biomedica Partners With Korean Gene Therapy Company

May 26, 1999

Biotech Salmon In The Pink

May 26, 1999

Celltech On Track To File U.S. NDA In Third Quarter

May 26, 1999

Alizyme Gets OK For Phase II On Renzapride

May 26, 1999

Enzyme Prodrug Company In Vector Deal With Vion

May 19, 1999

Centocor Seeking Stock For Trinitys Default

May 19, 1999

Nexias Cloned Goats Aid Spider-Silk Effort

May 19, 1999

Medullary Breast Cancer Gene Clue Discovered

May 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...